Literature DB >> 29163966

Risk factors and survival outcomes of biliary complications after adult-to-adult living donor liver transplantation.

Seogsong Jeong1, Xin Wang1, Ping Wan1, Meng Sha1, Jianjun Zhang1, Lei Xia1, Ying Tong1, Yi Luo1, Qiang Xia1.   

Abstract

The objective of this study was to evaluate the risk factors and survival outcomes of biliary complications (BCs) after living donor liver transplantation (LDLT) based on our single-center experience. From 2007 to 2010, 112 adult patients were assessed. Forty-nine patients (43.8%) experienced at least one episode of BCs, including biliary stricture and bile leak, occurring in 37.5% and 16.1% of the patients, respectively. Multivariate analysis indicated that hepatic artery thrombosis (relative risk (RR), 5.692; 95% CI, 2.132 to 15.201; p < 0.001), a hepatic duct diameter of less than 3 mm (RR, 2.523; 95% CI, 1.295 to 4.914; p = 0.005), ductoplasty (RR, 2.175; 95% CI, 1.134 to 4.174; p = 0.018), and cytomegalovirus infection (RR, 4.452; 95% CI, 1.868 to 10.613; p = 0.001) were independent risk factors for the development of BCs. However, these factors and BCs showed no prominent impact on the overall survival (OS) and graft survival (GS). In addition, the patients who developed vascular complications demonstrated poor outcomes in terms of OS (five-year, 56.3% vs. 78.1%; p = 0.017), GS (five-year, 56.3% vs. 77.1%; p = 0.023), and BC-free survival (five-year, 25.0% vs. 63.5%; p = 0.007) compared with patients without vascular complications. In conclusion, BCs remain a common problem after LDLT, especially for patients using duct-to-duct anastomosis. Hepatic artery thrombosis, a short duct diameter, ductoplasty, and cytomegalovirus infection lead to an increased incidence of BCs. The occurrence of BCs manifested no significant influence on the long-term survival outcomes. However, our findings await verification through large-scale randomized studies regarding the risk factors for the development of BCs and their impact on the prognosis.

Entities:  

Keywords:  Living donor liver transplantation; bile leak; biliary complications; biliary stricture; duct-to-duct anastomosis; risk factors; survival outcomes; vascular complications

Year:  2017        PMID: 29163966      PMCID: PMC5676543          DOI: 10.1177/2050640616688994

Source DB:  PubMed          Journal:  United European Gastroenterol J        ISSN: 2050-6406            Impact factor:   4.623


  35 in total

Review 1.  Biliary reconstruction and complications in adult living donor liver transplantation: systematic review and meta-analysis.

Authors:  S Zhang; M Zhang; Q Xia; J-J Zhang
Journal:  Transplant Proc       Date:  2014 Jan-Feb       Impact factor: 1.066

2.  Single-center experience of living donor liver transplantation in patients with portal vein thrombosis.

Authors:  Sanghyun Song; Choon Hyuck David Kwon; Jong Man Kim; Jae-Won Joh; Suk-Koo Lee
Journal:  Clin Transplant       Date:  2016-08-04       Impact factor: 2.863

3.  Segmental liver transplantation from a living donor.

Authors:  B Smith
Journal:  J Pediatr Surg       Date:  1969-02       Impact factor: 2.545

4.  Major vascular complications in living-donor liver transplant recipients: single center team experience.

Authors:  Refaat Kamel; Yasser Hatata; Mohamed Taha; Karim Hosny; Ayman Amin
Journal:  Exp Clin Transplant       Date:  2015-04       Impact factor: 0.945

5.  Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium.

Authors:  Kim M Olthoff; Robert M Merion; Rafik M Ghobrial; Michael M Abecassis; Jeffrey H Fair; Robert A Fisher; Chris E Freise; Igal Kam; Timothy L Pruett; James E Everhart; Tempie E Hulbert-Shearon; Brenda W Gillespie; Jean C Emond
Journal:  Ann Surg       Date:  2005-09       Impact factor: 12.969

6.  Cytomegalovirus infection: its incidence and management in cytomegalovirus-seropositive living related liver transplant recipients: a single-center experience.

Authors:  Manav Wadhawan; Subash Gupta; Neerav Goyal; Karisangal R Vasudevan; Kausar Makki; Reetika Dawar; Raman Sardana; Nand Lal; Ajay Kumar
Journal:  Liver Transpl       Date:  2012-12       Impact factor: 5.799

7.  Cytomegalovirus infection and development of biliary complications after liver transplantation.

Authors:  Leena Halme; Krister Hockerstedt; Irmeli Lautenschlager
Journal:  Transplantation       Date:  2003-06-15       Impact factor: 4.939

8.  Long-term incidence, risk factors, and management of biliary complications after adult living donor liver transplantation.

Authors:  Shin Hwang; Sung-Gyu Lee; Kyu-Bo Sung; Kwang-Min Park; Ki-Hun Kim; Chul-Soo Ahn; Young-Joo Lee; Sung-Koo Lee; Gyu-Sam Hwang; Deok-Bog Moon; Tae-Yong Ha; Dong-Sik Kim; Jae-Pil Jung; Gi-Won Song
Journal:  Liver Transpl       Date:  2006-05       Impact factor: 5.799

9.  The right small-for-size graft results in better outcomes than the left small-for-size graft in adult-to-adult living donor liver transplantation.

Authors:  Nam-Joon Yi; Kyung-Suk Suh; Yong Beom Cho; Hae Won Lee; Eung-Ho Cho; Jai Young Cho; Woo Young Shin; Joohyun Kim; Kuhn Uk Lee
Journal:  World J Surg       Date:  2008-08       Impact factor: 3.352

10.  Risk factors and criteria predicting early graft loss after adult-to-adult living donor liver transplantation.

Authors:  ZhengGui Du; YongGang Wei; KeFei Chen; Xi Chen; ZhiJun Zhang; HongYu Li; Yu Ma; Bo Li
Journal:  J Surg Res       Date:  2013-10-29       Impact factor: 2.192

View more
  2 in total

1.  Biliary complications in recipients of living donor liver transplantation: A single-centre study.

Authors:  Reginia Nabil Guirguis; Ehab Hasan Nashaat; Azza Emam Yassin; Wesam Ahmed Ibrahim; Shereen A Saleh; Mohamed Bahaa; Mahmoud El-Meteini; Mohamed Fathy; Hany Mansour Dabbous; Iman Fawzy Montasser; Manar Salah; Ghada Abdelrahman Mohamed
Journal:  World J Hepatol       Date:  2021-12-27

Review 2.  Advantages of using indocyanine green in liver transplantation: a narrative review.

Authors:  Bo Dai; Nida El Islem Guissi; Lydia Frenzel Sulyok; Mitchell G Bryski; Yiqing Wang; Dongjin Wang; Sunil Singhal; Huiming Cai
Journal:  Ann Transl Med       Date:  2022-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.